Caphosol, a therapeutic option in cancer therapy induced mucositis in children.

Phase 3

• Conditions: mucositis; denture sore mouth.; Stomatitis

• Registration Number: NL-OMON35477
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Cancer therapy induced mucositis
Hospitalization
Age 4-18 years

Exclusion Criteria

Previous Caphosol use
Previous study participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Duration of mucositis.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Pain.</p><br>